Amy_Weinfeld_Schulman

Amy Weinfeld Schulman

Amy Weinfeld Schulman

Buisnessperson

Amy Weinfeld Schulman is an American venture capitalist who serves as a managing partner at Polaris Partners.[1][2][3] She focused on investing in healthcare companies and early-stage biotech start-ups.[2][4] She also chairs the Board of Directors for Alnylam Pharmaceuticals (NASDAQ: ALNY)[5] and ByHeart,[6][7] and represents Polaris as a director for Kallyope, Thirty Madison, QurAlis, and Larkspur.[8]

Education

She is a Phi Beta Kappa graduate of Wesleyan University, where she received a joint degree in philosophy and English, and she obtained her J.D. from Yale Law School.[2][4][9]

Career

Before joining Polaris in 2014, Amy held various roles at Pfizer.[10] Initially serving as the general counsel, she later transitioned to the business side,[4] becoming the president of both Pfizer Nutrition and Pfizer Consumer Healthcare.[11][12] Prior to her tenure at Pfizer, she practiced law as a partner at DLA Piper and began her career in litigation at Cleary Gottlieb Steen & Hamilton in 1991.[13][14]

References

  1. [1]
    "Amy Schulman | Polaris Partners". Retrieved 2024-03-22.
  2. [2]
    "Ms. Amy Schulman - Board of Trustees". board.caltech.edu. Retrieved 2024-03-22.
  3. [3]
    "Amy Schulman Elected as New Caltech Trustee". California Institute of Technology. 2023-09-13. Retrieved 2024-03-22.
  4. [4]
    "Amy Schulman '89 | Yale Law School". law.yale.edu. Retrieved 2024-03-22.
  5. [5]
    "Alnylam Elects Amy Schulman to its Board of Directors". fiercepharma.com.
  6. [6]
    ByHeart. "ByHeart Appoints Amy Schulman as Chair of the Board of Directors, Further Solidifying its Position as a Leader in the Infant Nutrition Category". www.prnewswire.com (Press release). Retrieved 2024-03-22.
  7. [7]
    "ByHeart adds Amy Schulman and Hemi Zucker to Board along with raising $70m Series A financing led by Polaris Partners, OCV Partners and D1 Capital Partners". talent4boards.com.
  8. [8]
    "Amy Schulman". www.astp4kt.eu. Retrieved 2024-03-22.
  9. [9]
    "Trustees Emeriti, Board of Trustees - Wesleyan University". www.wesleyan.edu. Retrieved 2024-03-22.
  10. [10]
    "Ex-Pfizer exec Schulman lands at Polaris after an abrupt departure". fiercebiotech.com.
  11. [11]
    "Amy Schulman". Cardurion. Retrieved 2024-03-22.
  12. [12]
    "Amy Schulman, tapped to lead a new Pfizer division, makes an abrupt exit". fiercepharma.com.
  13. [13]
    "Leadership in Law: Amy Schulman at DLA Piper - Case - Faculty & Research - Harvard Business School". www.hbs.edu. Retrieved 2024-03-22.
  14. [14]
    "Pfizer's Amy Schulman on What Women Need to Succeed in their Careers". Knowledge at Wharton. Retrieved 2024-03-22.
Share this article:

This article uses material from the Wikipedia article Amy_Weinfeld_Schulman, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.